EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis

Fayhan J Alroqi, Musaab A Alhezam, Abdullah I Almojali, Tlili Barhoumi, Nouf Althubaiti, Yousef Alharbi, Mohammed A Al Balwi, Abdulrahman Alrasheed

Journal of Clinical Immunology · 2024-04 · 44 (3)

DOI: 10.1007/s10875-024-01674-0 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Immunology, online erschienen am 01.03.2024. Verfasst von Fayhan J Alroqi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy and Immunology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, R…. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Severe Combined Immunodeficiency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Major histocompatibility complex (MHC) class II deficiency is one of the combined immune deficiency disorders caused by defects in the MHC class II regulatory genes leading to abnormal T cells development and function. Therefore, patients mainly present with increased susceptibility to infections, diarrhea, and failure to thrive. In this report, we present one MHC class II deficient patient with a novel presentation with Hemophagocytic Lymphohistiocytosis (HLH).

Methods

Immunophenotyping of lymphocyte subpopulations and HLA-DR expression was assess by flow cytometry. Gene mutational analysis was performed by whole exome and Sanger sequencing.

Results

We reported a 7-year-old girl, who was diagnosed at age of 2 years with MHC class II deficiency by genetic testing and flow cytometry. Two years later, she developed disseminated BCGitis which was treated with proper antimicrobial agents. At the age of 7 years, she presented with clinical features fulfilling 6 diagnostic criteria of HLH including evidence of hemophagocytic activity in bone marrow aspiration. Accordingly, the diagnosis of HLH was established and the patient was started on IV Dexamethasone, Anakinra and IVIG. Eventually, patient started to improve and was discharged in good condition. Few months later, the patient was readmitted with severe pneumonia and sepsis leading to death.

Conclusion

Patients with MHC class II deficiency might present with disseminated BCGitis especially if the patient has severe T cell lymphopenia. Additionally, this immune defect might be added to the list of inborn errors of immunity that can be complicated with HLH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticSevere Combined ImmunodeficiencyChildFemaleHumansGenetic TestingHistocompatibility Antigens Class IIMajor Histocompatibility Complex

Stichwörter der Autor:innen

HLHHyperinflammationMHC-II deficiencyRFXANKTuberculosis

Substanzen

Histocompatibility Antigens Class II

Autor:innen und Institutionen

  • Division of Pediatric Allergy and Immunology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, Riyadh, 14611, Saudi Arabia. Rogif1465@gmail.com.
  • King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, Riyadh, 14611, Saudi Arabia. Rogif1465@gmail.com.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, 14611, Saudi Arabia. Rogif1465@gmail.com.
  • Division of Pediatric Allergy and Immunology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, Riyadh, 14611, Saudi Arabia.
  • King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, Riyadh, 14611, Saudi Arabia.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, 14611, Saudi Arabia.

Zitieren

APA

Alroqi, F. J., Alhezam, M. A., Almojali, A. I., Barhoumi, T., Althubaiti, N., Alharbi, Y., Al Balwi, M. A., & Alrasheed, A. (2024). Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology, 44(3). https://doi.org/10.1007/s10875-024-01674-0

Vancouver

Alroqi FJ, Alhezam MA, Almojali AI, Barhoumi T, Althubaiti N, Alharbi Y, et al. Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 2024;44(3). doi:10.1007/s10875-024-01674-0

BibTeX
@article{Alroqi2024,
  author = {Alroqi, Fayhan J and Alhezam, Musaab A and Almojali, Abdullah I and Barhoumi, Tlili and Althubaiti, Nouf and Alharbi, Yousef and Al Balwi, Mohammed A and Alrasheed, Abdulrahman},
  title = {Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis},
  journal = {Journal of Clinical Immunology},
  year = {2024},
  volume = {44},
  number = {3},
  doi = {10.1007/s10875-024-01674-0}
}
Kostenlos starten →